SERB began in the 1950s as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research).

For over 30 years we have consistently supplied emergency medicines, medical countermeasures, and the world’s leading portfolio of antidotes. In this time, we have built trusted partnerships, integrated infrastructure and quality processes to get our medicines to patients with urgency.

Our proven ability to acquire, develop, manufacture, launch and commercialize specialist medicines allows us to meet critical medical needs.

Improving patients’ quality of life and offering hope is what motivates and inspires us.